Protein acetylation and related potential therapeutic strategies in kidney disease
Pharmacological Research · 2023-11 · 197 · 106950
DOI: 10.1016/j.phrs.2023.106950 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2023-11. Verfasst von Xiang-Yu Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Educ…. Hauptthemen laut MEDLINE: Kidney Diseases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kidney disease can be caused by various internal and external factors that have led to a continual increase in global deaths. Current treatment methods can alleviate but do not markedly prevent disease development. Further research on kidney disease has revealed the crucial function of epigenetics, especially acetylation, in the pathology and physiology of the kidney. Histone acetyltransferases (HATs), histone deacetylases (HDACs), and acetyllysine readers jointly regulate acetylation, thus affecting kidney physiological homoeostasis. Recent studies have shown that acetylation improves mechanisms and pathways involved in various types of nephropathy. The discovery and application of novel inhibitors and activators have further confirmed the important role of acetylation. In this review, we provide insights into the physiological process of acetylation and summarise its specific mechanisms and potential therapeutic effects on renal pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, the Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui…
- School of Life Sciences, Anhui Medical University, Hefei 230032, China.
- Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei 230601, Anhui, China.
- Department of Clinical Pharmacy, Anhui Provincial Children's Hospital, Hefei 230051, China.
- Research Center for Translational Medicine, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
- School of Basic Medicine, Anhui Medical University, Hefei 230032, China. Electronic address: ShaoWei@ahmu.edu.cn.
Zitieren
APA
Li, X. Y., Yu, J. T., Dong, Y. H., Shen, X. Y., Hou, R., Xie, M. M., Wei, J., Hu, X. W., Dong, Z. H., Shan, R. R., Jin, J., Shao, W., & Meng, X. M. (2023). Protein acetylation and related potential therapeutic strategies in kidney disease. Pharmacological Research, 197, 106950. https://doi.org/10.1016/j.phrs.2023.106950
Vancouver
Li XY, Yu JT, Dong YH, Shen XY, Hou R, Xie MM, et al. Protein acetylation and related potential therapeutic strategies in kidney disease. Pharmacological Research. 2023;197:106950. doi:10.1016/j.phrs.2023.106950
BibTeX
@article{Li2023,
author = {Li, Xiang-Yu and Yu, Ju-Tao and Dong, Yu-Hang and Shen, Xiao-Yu and Hou, Rui and Xie, Man-Man and Wei, Jie and Hu, Xiao-Wei and Dong, Ze-Hui and Shan, Run-Run and Jin, Juan and Shao, Wei and Meng, Xiao-Ming},
title = {Protein acetylation and related potential therapeutic strategies in kidney disease},
journal = {Pharmacological Research},
year = {2023},
volume = {197},
pages = {106950},
doi = {10.1016/j.phrs.2023.106950}
}
EUVIMED